NARI Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Inari Medical Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 41.6 USD 11.41%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast NARI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NARI is 74.65 USD with a low forecast of 47.47 USD and a high forecast of 105 USD.

NARI Lowest Forecast

Wall Street Target

NARI Average Forecast

Wall Street Target

NARI Highest Forecast

Wall Street Target

14% Upside

79% Upside

152% Upside

The latest public price target was made on May 1, 2024 by Adam Maeder from Piper Sandler , who expects NARI stock to rise by 20% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Adam Maeder Piper Sandler	50 USD Upside 20%	1 day ago May 1, 2024	Inari Medical Inc. (NARI) PT Lowered to $50 at Piper Sandler StreetInsider

Price Target	50 USD
Upside/Downside	20%

Beijing Bohui Innovation Biotechnology Group Co Ltd

58% Upside

Nanalysis Scientific Corp

195% Upside

Lutronic Corp

10% Downside

Nakanishi Inc

33% Upside

Beijing Bohui Innovation Biotechnology Group Co Ltd

58% Upside

Nanalysis Scientific Corp

195% Upside

Lutronic Corp

10% Downside

Nakanishi Inc

33% Upside

Terumo Corp

13% Upside

Apex Biotechnology Corp

124% Upside

Medtronic PLC

19% Upside

Shenzhen Mindray Bio-Medical Electronics Co Ltd

32% Upside

Revenue
Forecast

For the last 4 years the compound annual growth rate for Inari Medical Inc's revenue is 76%. The projected CAGR for the next 3 years is 19%.

76%

19%

-1%

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

-7%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-11%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for NARI is 74.65 USD with a low forecast of 47.47 USD and a high forecast of 105 USD.

For the last 4 years the compound annual growth rate for Inari Medical Inc's revenue is 76%. The projected CAGR for the next 3 years is 19%.

Join more than 133,400+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.